https://finance.yahoo.com/news/abbotts-freestyle-libre-14-day-140700332.html
Maybe beginning of new trend that hospital staff will recognize the advantage of cgm for patients under their care. With COVID patients, they can minimize contact with patient, but still monitor BG trends.
From link:
FreeStyle Libre 14 day system can be used by frontline healthcare workers in hospitals to remotely monitor patients with diabetes who can scan² to minimize exposure to COVID-19 and preserve use of personal protective equipment (PPE)
– In partnership with the American Diabetes Association (ADA), Abbott will donate 25,000 FreeStyle Libre 14 day sensors to U.S. hospitals and medical centers in outbreak hotspots to help accelerate access to technology
“Leading cgm”
3 Data on file, Abbott Diabetes Care. Data based on the number of users worldwide for the FreeStyle Libre system compared to the number of users for other leading personal use, sensor-based glucose monitoring systems
